Pending — not yet graded
“Downgraded Inventurus Knowledge Solutions (IKS Health) to 'hold' from 'buy', with a target price of ₹1,860 per share, which is 2.6% higher than the previous closing price. The downgrade to 'hold' suggests a more cautious or neutral stance despite a modest upside target.”
Jefferies Analysis’s track record: 3 graded calls · 95% CI 44–100%
Inventurus Knowledge SolutionsNeutralCalled 20 Aug 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.
Read the original articleSee Jefferies Analysis’s full track record